NCT03476980

Brief Summary

An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received UCM or DCC. This prospective multi-national randomized controlled trial (RCT) is a two-arm parallel non-inferiority design of two alternative approaches of treatment.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
4 countries

18 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2018

Completed
1.3 years until next milestone

Study Start

First participant enrolled

July 6, 2019

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

5.4 years

First QC Date

March 19, 2018

Last Update Submit

November 22, 2022

Conditions

Keywords

Neurodevelopmental impairment, prematurityDisabilityUmbilical cord milkingDelayed cord clamping

Outcome Measures

Primary Outcomes (1)

  • Developmental Outcome

    Bayley Scales of Infant Development (BSID), 3rd or 4th Ed. Composite Score (cognitive 55-145, language 45-155, motor 45-155; higher scores are better)

    22-26 months corrected gestational age (CGA). All assessments may be extended to 42 months CGA due to Covid-19 pandemic.

Secondary Outcomes (12)

  • Moderate/Severe Neurodevelopmental Impairment

    22-26 months corrected gestational age

  • Mild Neurodevelopmental Impairment

    22-26 months corrected gestational age

  • Gross Motor Function Classification System Scale (GMFCS)

    22-26 months corrected gestational age

  • Cerebral Palsy (CP)

    22-26 months corrected gestational age

  • Developmental Outcomes assessed by Ages & Stages Questionnaire, 3rd ed. (ASQ-3) five domains: Communication, Gross motor, Fine motor, Problem solving and Personal-social in infants born between 23-32+6 weeks GA who received UCM or DCC.

    22-26 months corrected gestational age

  • +7 more secondary outcomes

Other Outcomes (4)

  • Exploratory, hypothesis-generating

    From birth through hospital discharge, up to 6 months corrected gestational age (CGA)

  • Exploratory, hypothesis-generating

    4 hours of life +/- 2 hours

  • Exploratory, hypothesis-generating

    In the first 10 minutes of life

  • +1 more other outcomes

Study Arms (2)

Randomized to Umbilical Cord Milking at birth

ACTIVE COMPARATOR

Milking the umbilical cord towards the infant at a speed of 20cm/2seconds at birth.

Procedure: Randomized to Umbilical Cord Milking at birth

Randomized to Delayed Cord Clamping at birth

ACTIVE COMPARATOR

Delayed clamping of the umbilical cord at birth.

Procedure: Randomized to Delayed Cord Clamping at birth

Interventions

The subjects in this group were randomized to UCM X4 at birth. This procedure infuses a placental transfusion of blood by milking the umbilical cord towards the infant at birth.

Also known as: UCM
Randomized to Umbilical Cord Milking at birth

The subjects in this group were randomized to DCC at birth. At delivery, the obstetrician was instructed to delay clamping of the umbilical cord for 60 seconds.

Also known as: DCC
Randomized to Delayed Cord Clamping at birth

Eligibility Criteria

Age22 Months - 42 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children enrolled in the PREMOD2 non-inferiority trial at birth who survive to 2 years corrected age.

You may not qualify if:

  • Children enrolled in the PREMOD2 non-inferiority trial at birth who did not survive or are lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

University of Alabama

Birmingham, Alabama, 35294-0004, United States

RECRUITING

Loma Linda Medical Center

Loma Linda, California, 92350, United States

RECRUITING

LAC+USC Medical Center

Los Angeles, California, 90033, United States

RECRUITING

PIH Health Good Samaritan Hospital

Los Angeles, California, 90033, United States

RECRUITING

University of California, Irvine Medical Center

Orange, California, 92868, United States

RECRUITING

Sharp Grossmont Hospital

San Diego, California, 91942, United States

RECRUITING

Sharp Mary Birch Hospital for Women and Newborns

San Diego, California, 92123, United States

RECRUITING

Christiana Care

Newark, Delaware, 19718, United States

RECRUITING

John H. Stroger, Jr. Hospital of Cook County

Chicago, Illinois, 60612, United States

RECRUITING

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

RECRUITING

St. Louis University

St Louis, Missouri, 63104, United States

RECRUITING

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States

RECRUITING

Providence St. Vincent Medical Center

Portland, Oregon, 97225-6603, United States

RECRUITING

Magee-Womens Hospital

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

University of Utah

Salt Lake City, Utah, 84112, United States

RECRUITING

Governors of University of Alberta

Edmonton, Alberta, T6G 2R3, Canada

RECRUITING

University of ULM

Ulm, Baden-Wurttemberg, 89075, Germany

RECRUITING

Cork University Maternity Hospital

Cork, Ireland

RECRUITING

Related Publications (2)

  • Katheria A, Garey D, Truong G, Akshoomoff N, Steen J, Maldonado M, Poeltler D, Harbert MJ, Vaucher YE, Finer N. A Randomized Clinical Trial of Umbilical Cord Milking vs Delayed Cord Clamping in Preterm Infants: Neurodevelopmental Outcomes at 22-26 Months of Corrected Age. J Pediatr. 2018 Mar;194:76-80. doi: 10.1016/j.jpeds.2017.10.037. Epub 2017 Dec 12.

    PMID: 29246467BACKGROUND
  • Katheria AC, Truong G, Cousins L, Oshiro B, Finer NN. Umbilical Cord Milking Versus Delayed Cord Clamping in Preterm Infants. Pediatrics. 2015 Jul;136(1):61-9. doi: 10.1542/peds.2015-0368.

    PMID: 26122803BACKGROUND

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Anup Katheria, MD

    Sharp Mary Birch Hospital for Women & Newborns

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anup Katheria, MD

CONTACT

Jane Steen, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Neurodevelopmental assessments will be done at 2 years of corrected age (22-26 months) for subjects who were randomized at birth to receive either delayed cord clamping or umbilical cord milking as part of the PREMOD2 trial. This prospective multi-national randomized controlled trial (RCT) is a two-arm parallel non-inferiority design of two alternative approaches of treatment.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

March 26, 2018

Study Start

July 6, 2019

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

November 25, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

Data will be made available per NICHD requirements (National Institute of Child Health and Human Development).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
2 years after primary publication
Access Criteria
An archived dataset with documentation will be made available for additional uses by outside investigators, in collaboration with the study investigators.
More information

Locations